Targeting the vascular dysfunction: Potential treatments for preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Maternal-Fetal Medicine

Background:

• Preeclampsia is a pregnancy-specific disorder characterized by new-onset hypertension and signs of maternal or fetal compromise.
• The underlying pathophysiology involves systemic maternal vascular dysfunction driven by placental factors like anti-angiogenic proteins.
• Current management relies on delivery, often preterm, highlighting the need for targeted therapies.

Purpose of the Study:

• To review the vascular effects of drugs under clinical investigation for preeclampsia treatment.
• To explore novel therapeutic strategies addressing maternal vascular dysfunction.

Main Methods:

• Review of clinical trials and scientific literature on drug candidates for preeclampsia.
• Analysis of mechanisms of action focusing on vascular effects.

Main Results:

• Preeclampsia involves impaired vascular regulation, increased vasoconstriction, and oxidative stress.
• Dysfunctional placenta releases anti-angiogenic factors contributing to vascular damage.
• Several drugs are being assessed for their potential to mitigate these vascular effects.

Conclusions:

• Targeting maternal vascular dysfunction offers a promising avenue for preeclampsia treatment.
• Effective therapies could reduce the need for preterm delivery and its associated risks.
• Further research into these drug candidates is crucial for clinical application.